Home › Funds › BML Capital Management, LLC › IMA
BML Capital Management, LLC position in IMA
IMAGENEBIO INC · Health Care
BML Capital Management, LLC reported holding 200,730 shares of IMA (IMAGENEBIO INC) in its Q3 2026 13F filing — a position valued at US$919K, representing 0.49% of its reported portfolio and ranking #17 among its reported holdings. BML Capital Management, LLC has disclosed IMA holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How BML Capital Management, LLC's IMA position evolved
BML Capital Management, LLC first disclosed a stake in IMA in Q3 2025 at 182,509 shares (US$1.5M). Across 5 filings, BML Capital Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 200,730 shares valued at US$919K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 182.51K | $1.49M | New |
| Q4 2025 | 177.03K | $1.22M | Reduce |
| Q1 2026 | 200.73K | $1.00M | Add |
| Q2 2026 | 200.73K | $1.18M | Hold |
| Q3 2026 | 200.73K | $919.34K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMA and 13F data
IMA (IMAGENEBIO INC) is a Health Care company. 38 other funds we track also report a position in IMA — the largest reported positions include BVF INC/IL (US$6.5M), Blue Owl Capital Holdings LP (US$5.2M), Cable Car Capital, LP (US$4.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMA
- BVF INC/IL 1.11M sh · $6.55M · Q2 2026
- Blue Owl Capital Holdings LP 1.14M sh · $5.20M · Q3 2026
- Cable Car Capital, LP 781.60K sh · $4.61M · Q2 2026
- Omega Fund Management, LLC 455.36K sh · $2.69M · Q2 2026
- Trails Edge Capital Partners, LP 282.00K sh · $1.66M · Q2 2026
- Monashee Investment Management LLC 177.09K sh · $811.09K · Q3 2026
- NEA Management Company, LLC 50.01K sh · $295.03K · Q2 2026
- Aldebaran Capital, LLC 17.75K sh · $81.28K · Q3 2026
More on BML Capital Management, LLC
FAQ
How long has BML Capital Management, LLC held IMA?
BML Capital Management, LLC has disclosed IMA holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is BML Capital Management, LLC's current position in IMA?
As of Q3 2026, BML Capital Management, LLC holds 200.73K shares of IMA (IMAGENEBIO INC), valued at $919.34K, representing 0.49% of its reported portfolio and ranking #17.
Has BML Capital Management, LLC been buying or selling IMA?
In the latest 13F filing (Q3 2026), BML Capital Management, LLC held unchanged its position in IMA.
Which other funds hold IMA?
Other major institutional holders of IMA include BVF INC/IL, Blue Owl Capital Holdings LP, Cable Car Capital, LP, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.